Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06453980

Multimodal Investigation of Neural Plasticity

This study will evaluate the effects of a form of non-invasive brain stimulation on brain functioning and memory in cognitively intact older adults (healthy controls, HC) and in those with mild cognitive impairment (MCI).

Recruiting

Interested in participating?

Request Info

Key information

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location status: Recruiting

Location contact

Alexandru Iordan, Ph.D

CONTACT

[email protected]

734-764-2909

Alexandru Iordan, Ph.D

PRINCIPAL_INVESTIGATOR

About this study

The goal of this study is to learn important information about the effects of weak electrical stimulation (known as high-definition transcranial direct current stimulation or HD-tDCS) on brain functioning in those with mild cognitive impairment (MCI). The findings will help determine how stimulation affects brain's activity and metabolism (in particular, the neurotransmitter glutamate). Ultimately, this information may help develop new treatments for those with Alzheimer's disease. The study will use different forms of brain imaging to see whether stimulation changes how the brain responds during a memory task. Functional magnetic resonance spectroscopy (fMRS), functional magnetic resonance imaging (fMRI), and functional near-infrared spectroscopy (fNIRS) will be used. The study also uses cognitive tests and questionnaires.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Normal cognition for HC and diagnosis of Mild Cognitive Impairment (MCI) for MCI participants
  • Right-handedness
  • Magnetic resonance compatible, criteria that also apply for high definition transcranial direct current stimulation (HD-tDCS; e.g., absence of metallic or electronic implants in the upper body or head)

Exclusion criteria

  • History of other contributing neurological or medical conditions known to affect cognitive functioning
  • Significant mental illness
  • Sensory impairments that limit ability to participate
  • History of alcohol or drug abuse/dependence

Treatment and study plan

Sham tDCS

Device

Participants will receive sham (placebo) HD-tDCS for 20 minutes, for 1 session.

active tDCS

Device

Participants will receive HD-tDCS at 3 milliAmp for 20 minutes, for 1 session.

Primary outcomes

  1. Changes in glutamate concentration (fMRS)

    Time frame: average on 1 week

    Analyses via fMRS using units of concentration

  2. Changes in brain activation (fMRI)

    Time frame: average of 1 week

    Analyses via fMRI using units of brain activation

Secondary outcomes

  1. Changes in memory performance

    Time frame: average of 1 week

    Analyses of memory performance indexed as percent accuracy

  2. Changes in brain activation (fNIRS)

    Time frame: immediate, concurrent with tDCS

    Analyses via fNIRS using units of brain activation

Study contacts

Contact information is provided by the study sponsor or research team.

Eileen Robinson, RN-BC

CONTACT

[email protected]

734-763-1356

Harini Babu, MSc

CONTACT

[email protected]

734-647-3704

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Collaborators

  • Alzheimer's Association
  • Wayne State University

Registry information

Official study title

Multimodal Investigation of Neural Plasticity Induced by Non-invasive Brain Stimulation

Acronym: miniSTIM

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Jun 12, 2024
Registry last updated
Mar 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.